Non-ischemic Dilated Cardiomyopathy: Clinical Trials

1 trial for Non-ischemic Dilated Cardiomyopathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Terminated 1

Follow Non-ischemic Dilated Cardiomyopathy: new trials by email Literature Review of Non-ischemic Dilated Cardiomyopathy trials Research Report on Non-ischemic Dilated Cardiomyopathy

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Microvascular Dysfunction in Nonischemic Cardiomyopathy: Insights From CMR Assessment of Coronary Flow Reserve
Regadenoson, Adenosine - Hypertrophic Cardiomyopathy, Non-ischemic Dilated Cardiomyopathy
Phase 4TerminatedDuke University312017-09-052020-09-16

Narrower conditions

Cardiomyopathy, Hypertrophic (1)

Broader conditions

Aortic Stenosis, Subvalvular (1)  ·  Aortic Valve Disease (1)  ·  Aortic Valve Stenosis (1)  ·  Cardiomyopathies (1)  ·  Cardiovascular Diseases (1)  ·  Heart Diseases (1)  ·  Heart Valve Diseases (1)

Interventions

Adenosine (1)  ·  regadenoson (1)

Sponsors

Duke University (1)

Countries

United States (1)

Top investigators

Han Kim (1)